Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Diabetes Mellitus, Type 2 1 Diabetes Mellitus 1

Interventions

pembrolizumab 382 Carboplatin 279 Specimen Handling 266 Nivolumab 256 Magnetic Resonance Spectroscopy 247 Cyclophosphamide 242 Cisplatin 217 Paclitaxel 208 Radiotherapy 196 Biopsy 171 Gemcitabine 158 Dexamethasone 149 durvalumab 148 atezolizumab 128 Rituximab 123 Doxorubicin 117 Bevacizumab 115 Ipilimumab 114 Lenalidomide 113 Radiation 111 Pemetrexed 104 Docetaxel 104 Etoposide 102 venetoclax 98 fludarabine 97 Radiosurgery 94 Capecitabine 94 Fluorouracil 93 Oxaliplatin 91 Prednisone 90

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × saxagliptin × 1 year × Clear all

NCT07033585 2025-07-11

GD-T2D

Medicine Invention Design, Inc

Phase 2/3 Active not recruiting

Diabetes Mellitus, Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡